Skip Navigation

European Journal of Heart Failure 2005 7(4):689-695; doi:10.1016/j.ejheart.2004.09.011
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ohtsuka, T.
Right arrow Articles by Higaki, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ohtsuka, T.
Right arrow Articles by Higaki, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society of Cardiology

Serum markers of angiogenesis and myocardial ultrasonic tissue characterization in patients with dilated cardiomyopathy

Tomoaki Ohtsuka*, Katsuji Inoue, Yuji Hara, Norikatsu Morioka, Kiyotaka Ohshima, Jun Suzuki, Akiyoshi Ogimoto, Yuji Shigematsu and Jitsuo Higaki

The Second Department of Internal Medicine, Ehime University School of Medicine Shigenobu, Onsen-gun, Ehime 791-0295, Japan

* Corresponding author. Tel.: +81 89 960 5302; Fax: +81 89 960 5306. E-mail address: tohtsuka{at}m.ehime-u.ac.jp


   Abstract

Background and aims: It has been proven that a disturbance in angiogenesis contributes to the progression of myocardial interstitial fibrosis in idiopathic dilated cardiomyopathy (DCM). This study was designed to evaluate the relationship between serum activity of angiogenic factors and myocardial ultrasonic tissue characterization in patients with DCM.

Methods and results: We studied 30 patients with DCM and 15 healthy control subjects. Serum levels of vascular endothelial growth factor (VEGF), interleukin (IL)-4 and IL-13 were measured using enzyme-linked immunosorbent assay. We determined calibrated myocardial integrated backscatter (IB) as the value of myocardial interstitial fibrosis using ultrasonic tissue characterization and also quantified the magnitude of cyclic variations in IB (CV-IB). Serum levels of VEGF and IL-13 were significantly higher in patients with DCM than in control subjects (both P<0.05). Calibrated IB was significantly higher and CV-IB was markedly lower in patients with DCM than in control subjects (both P<0.01). In patients with DCM, the levels of IL-13 significantly correlated with calibrated IB (r=0.520, P=0.018). In addition, there was a significant negative correlation between levels of VEGF and CV-IB (r=–0.611, P=0.007).

Conclusion: The increase in serum VEGF and IL-13 may be closely related to alterations in myocardial texture in DCM.

Key Words: Angiogenesis • Dilated cardiomyopathy • Ultrasonic tissue characterization

Received March 31, 2004; Revised July 13, 2004; Accepted September 20, 2004


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.